Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07079306

ChatGPT-Supported Text Messaging Program for Smoking Cessation

The current research proposal aims to explore how a purpose driven LLM ChatGPT chatbot, BeFreeBot, might enhance an evidence-based text messaging smoking cessation program, BeFree. The research will consist of a formative evaluation comparing quitting related outcomes among users of BeFree+Bot and BeFree.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Smoking Cessation Behavior Health Behavior

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Prolific

Washington D.C., District of Columbia, 20052, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • lives in the US
  • smoked a cigarette within the last 7 days
  • has a mobile phone
  • willing to receive text messages about the health effects of smoking on their mobile phone for 30 days

Exclusion criteria

  • none

Treatment and study plan

BeFree+Bot

Behavioral

Text messaging program called BeFree and access to BBot, ChatGPT chatbot

BeFree

Behavioral

Text messaging program called BeFree

Primary outcomes

  1. Continuous abstinence

    Time frame: at 1 month follow-up

    the longest continuous period (in days) that you did not smoke a cigarette

Study contacts

Contact information is provided by the study sponsor or research team.

Lorien Abroms, ScD

CONTACT

[email protected]

202-994-3518

Sponsors and collaborators

Lead sponsor

George Washington University

Other

Registry information

Official study title

Engagement and Satisfaction With a ChatGPT-Supported Text Messaging Program for Smoking Cessation

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Jul 23, 2025
Registry last updated
May 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.